Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1993-7-29
pubmed:abstractText
Cancer patients treated with anthracycline derivatives are at risk for perioperative cardiovascular decompensation. The authors studied hemodynamic performance before, during, and after laparotomy in 14 anthracycline-treated patients with ovarian carcinoma. General anesthesia was maintained with 70% N2O in O2, and patients were randomized to receive supplementation with either isoflurane, 0.59% end-tidal +/- 0.04 (mean +/- SE), or fentanyl, 2.67 micrograms/kg +/- 0.49 as a loading dose, and a total dose of 7.16 micrograms/kg +/- 0.71. The degree of hemodynamic stability relative to the baseline was assessed. There was no obvious superiority of either technique prior to the skin incision. However, during and immediately after surgery, a clearer tendency for isoflurane-N2O to result in better hemodynamic stability was found. Isoflurane-N2O demonstrated significantly smaller change scores in systemic vascular resistance (SVR) and cardiac index (CI). At the start of surgery, the isoflurane-N2O change in SVR was 228.08 dyne.sec.cm-5 compared to 479.58 for the fentanyl patients, (P = 0.002); at the end of surgery the corresponding means were -12.09 and 703.14 dyne.sec.cm-5, respectively, (P = 0.002). Isoflurane-N2O was associated with significantly greater CI stability in the early postoperative period: the isoflurane-N2O mean change was -0.081 L/min/m2, versus -0.993 for the fentanyl-N2O patients, (P = 0.005). The authors conclude that anthracycline-treated patients who do not have overt evidence of cardiomyopathy can be safely anesthetized with either anesthetic technique. However, during surgery and in the early postoperative period, an isoflurane-N2O technique appears to offer better hemodynamic stability.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1053-0770
pubmed:author
pubmed:issnType
Print
pubmed:volume
7
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
307-11
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:8518377-Acid-Base Imbalance, pubmed-meshheading:8518377-Anesthesia, Inhalation, pubmed-meshheading:8518377-Anesthesia, Intravenous, pubmed-meshheading:8518377-Antibiotics, Antineoplastic, pubmed-meshheading:8518377-Atrial Function, Right, pubmed-meshheading:8518377-Blood Pressure, pubmed-meshheading:8518377-Cardiac Output, pubmed-meshheading:8518377-Electrocardiography, pubmed-meshheading:8518377-Female, pubmed-meshheading:8518377-Fentanyl, pubmed-meshheading:8518377-Heart Rate, pubmed-meshheading:8518377-Hemodynamics, pubmed-meshheading:8518377-Humans, pubmed-meshheading:8518377-Isoflurane, pubmed-meshheading:8518377-Laparotomy, pubmed-meshheading:8518377-Middle Aged, pubmed-meshheading:8518377-Ovarian Neoplasms, pubmed-meshheading:8518377-Pulmonary Artery, pubmed-meshheading:8518377-Pulmonary Wedge Pressure, pubmed-meshheading:8518377-Risk Factors, pubmed-meshheading:8518377-Stroke Volume, pubmed-meshheading:8518377-Time Factors, pubmed-meshheading:8518377-Vascular Resistance, pubmed-meshheading:8518377-Ventricular Function, Left
pubmed:year
1993
pubmed:articleTitle
Isoflurane versus fentanyl: hemodynamic effects in cancer patients treated with anthracyclines.
pubmed:affiliation
Department of Anesthesiology and Critical Care Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial